Scott Rothbart

19 results.

November 28, 2018 High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets

GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…

September 13, 2018 Revealing the root causes of colon cancer: Three questions for Dr. Ali Lanctot Chomiak

Although the overall prevalence of colon cancer has steadily dropped since the 1980s, a close look at the data from recent years reveals a disturbing…

March 12, 2018 There is no “I” in “team”

How the smallest components of life work together to manage our epigenetic inheritance When it comes to understanding the intricate genetic architecture that makes us…

VAI DEFAULT HEADER
September 25, 2017 How getting back to the basics can improve human health

When the DNA double helix was first described more than 60 years ago, it sparked a scientific renaissance. It was a revolutionary milestone, but it…

September 20, 2017 $2.375 million federal award to study epigenetic control systems, inform drug discovery

GRAND RAPIDS, MI (Sept. 20, 2017)—Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing…

February 3, 2017 In their own words: The most exciting advances in cancer research

In honor of World Cancer Day on Saturday, we asked our scientists and collaborators a simple question—what do you think is…

January 11, 2017 Making an early impact: Three questions for Dr. Rochelle Tiedemann

The long road from student to independent scientist doesn’t necessarily end with earning a doctoral degree. Just as physicians complete a residency after finishing medical…

November 3, 2016 New computational tool may speed drug discovery

GRAND RAPIDS, Mich. (November 3, 2016)—A new computational tool called fABMACS is helping scientists see beyond static images of proteins to more…